Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-28 ANDO GORAN Director Grant or award · Stock Option (Right to Buy) +38,500 38,500
2020-02-28 Jones David Scott SVP & Chief Commercial Officer Grant or award · Restricted Stock Units +123,150 123,150
2020-02-28 Jones David Scott SVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +246,250 246,250
2020-02-28 Paggiarino Dario A. Chief Medical Officer Grant or award · Restricted Stock Units +123,150 123,150
2020-02-28 Paggiarino Dario A. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +246,250 246,250
2020-02-28 Lurker Nancy President & CEO Grant or award · Restricted Stock Units +374,000 374,000
2020-02-28 Lurker Nancy President & CEO Grant or award · Stock Option (Right to Buy) +748,000 748,000
2020-02-21 Lurker Nancy President & CEO Exercise or conversion +137,174 476,800
2020-02-21 Lurker Nancy President & CEO Exercise or conversion · Restricted Stock Units −137,174 274,349
2019-11-15 Elston George Chief Financial Officer Purchase +10,000 $1.43 $14K 10,000
2019-11-14 Elston George Chief Financial Officer Grant or award · Stock Options (Right to buy) +745,000 745,000
2019-10-12 Lurker Nancy President & CEO Shares withheld for taxes −10,745 $2.11 $23K 314,455
2019-10-12 Paggiarino Dario A. Chief Medical Officer Shares withheld for taxes −2,450 $2.11 $5K 43,047
2019-10-09 Mazzo David J Director Exercise or conversion +33,333 $1.95 $65K 200,083
2019-10-09 Mazzo David J Director Exercise or conversion · Stock Option (Right to Buy) −33,333 0
2019-09-06 Mazzo David J Director Exercise or conversion +417 166,750
2019-09-06 Mazzo David J Director Exercise or conversion · Deferred Stock Unit −417 0
2019-07-15 DICICCO WENDY F Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2019-06-27 Ross Leonard S Exercise or conversion +6,667 92,005
2019-06-27 Ross Leonard S Shares withheld for taxes −1,961 $1.65 $3K 90,044

Page 34 of 40 · 795 trades